Clinical Trial Update: Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

View source ↗

Summary

An ongoing clinical trial is investigating the role of TTV during first-line immunotherapy in patients with renal cell carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Renal Cell Carcinoma | Status: RECRUITING